FDA Orange Book · active-ingredient family
Iron dextran
Iron dextran is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:INFED · NDA 017441
4
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| INFEDRLD | ALLERGAN | NDA 017441 | BP | Approved Prior to Jan 1, 1982 | |
| DEXFERRUM | AM REGENT | NDA 040024 | — | Feb 23, 1996 | |
| IRON DEXTRAN | SANOFI AVENTIS US | NDA 010787 | — | Approved Prior to Jan 1, 1982 | |
| PROFERDEX | NEW RIVER | NDA 017807 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Iron dextran — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

